Key facts
- Earli CEO Cyriac Roeding discussed China's biotech sector.
- Roeding predicted a decade ago that China would become a main competitor to the US in biotech.
- He shared his assessment on Bloomberg's The China Show.
Cyriac Roeding, CEO and co-founder of the cancer therapeutics startup Earli, has provided his perspective on the advancements within China's biotechnology sector. Roeding recalled making a prediction ten years prior, stating that China would emerge as a significant competitor to the United States in the field of biotechnology. His insights were shared during an interview with Yvonne Man on Bloomberg's program, The China Show.